AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Nano Research Article
PDF (1.1 MB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Erratum

Erratum to: Boosting SN38-based oral chemotherapy to combine reduction-bioactivated structured lipid-mimetic prodrug with ascorbic acid

Helin Wang1,§, Qi Lu1,§, Yifan Miao1, Jiaxuan Song1, Mingyang Zhang1, Zixuan Wang1, Haotian Zhang2, Zhonggui He1, Chutong Tian1( ), Jin Sun1( )
Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, China
School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China

§ Helin Wang and Qi Lu contributed equally to this work.

Show Author Information
The online version of the original article can be found at:
https://doi.org/10.1007/s12274-022-4544-7

Keywords

oral chemotherapystructured lipid-mimetic prodrug7-ethyl-10-hydroxycamptothecin (SN38)ascorbic acid
Nano Research
Volume 16 Issue 4,
April 2023
Pages 6010-6011
DOI: 10.1007/s12274-022-5257-7
Cite this article:
Wang H, Lu Q, Miao Y, et al. Erratum to: Boosting SN38-based oral chemotherapy to combine reduction-bioactivated structured lipid-mimetic prodrug with ascorbic acid. Nano Research, 2023, 16(4): 6010-6011. https://doi.org/10.1007/s12274-022-5257-7

485

Views

29

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Altmetrics
Published: 18 November 2022
© Tsinghua University Press 2022
Return